AU2004222631B2 - MSSN dispersion and method for producing the same - Google Patents

MSSN dispersion and method for producing the same Download PDF

Info

Publication number
AU2004222631B2
AU2004222631B2 AU2004222631A AU2004222631A AU2004222631B2 AU 2004222631 B2 AU2004222631 B2 AU 2004222631B2 AU 2004222631 A AU2004222631 A AU 2004222631A AU 2004222631 A AU2004222631 A AU 2004222631A AU 2004222631 B2 AU2004222631 B2 AU 2004222631B2
Authority
AU
Australia
Prior art keywords
phase
active compound
nanoparticles
dispersion
aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2004222631A
Other languages
English (en)
Other versions
AU2004222631A1 (en
Inventor
Gerd Dahms
Holger Seidel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kemira Oyj
Original Assignee
Kemira Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kemira Oyj filed Critical Kemira Oyj
Publication of AU2004222631A1 publication Critical patent/AU2004222631A1/en
Assigned to KEMIRA PIGMENTS OY reassignment KEMIRA PIGMENTS OY Request for Assignment Assignors: IFAC GMBH & CO. KG
Application granted granted Critical
Publication of AU2004222631B2 publication Critical patent/AU2004222631B2/en
Assigned to KEMIRA OYJ reassignment KEMIRA OYJ Request for Assignment Assignors: KEMIRA PIGMENTS OY
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/5123—Organic compounds, e.g. fats, sugars
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/51—Nanocapsules; Nanoparticles
    • A61K9/5107—Excipients; Inactive ingredients
    • A61K9/513—Organic macromolecular compounds; Dendrimers
    • A61K9/5146—Organic macromolecular compounds; Dendrimers obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyamines, polyanhydrides
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Optics & Photonics (AREA)
  • Nanotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2004222631A 2003-03-21 2004-02-19 MSSN dispersion and method for producing the same Ceased AU2004222631B2 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10312763A DE10312763A1 (de) 2003-03-21 2003-03-21 Verfahren zur Herstellung einer SLN-Dispersion
DE10312763.1 2003-03-21
PCT/EP2004/001589 WO2004082666A2 (de) 2003-03-21 2004-02-19 Mssn-dispersion und verfahren zu ihrer herstellung

Publications (2)

Publication Number Publication Date
AU2004222631A1 AU2004222631A1 (en) 2004-09-30
AU2004222631B2 true AU2004222631B2 (en) 2009-02-26

Family

ID=32921086

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2004222631A Ceased AU2004222631B2 (en) 2003-03-21 2004-02-19 MSSN dispersion and method for producing the same

Country Status (8)

Country Link
US (1) US20060257334A1 (cg-RX-API-DMAC7.html)
EP (1) EP1605923A2 (cg-RX-API-DMAC7.html)
JP (1) JP2006520750A (cg-RX-API-DMAC7.html)
KR (1) KR20050114255A (cg-RX-API-DMAC7.html)
AU (1) AU2004222631B2 (cg-RX-API-DMAC7.html)
CA (1) CA2519697C (cg-RX-API-DMAC7.html)
DE (1) DE10312763A1 (cg-RX-API-DMAC7.html)
WO (1) WO2004082666A2 (cg-RX-API-DMAC7.html)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3428257B1 (en) 2003-09-29 2023-06-14 Deb IP Limited High alcohol content gel-like and foaming compositions
JP2007516259A (ja) 2003-12-09 2007-06-21 メッドクリスタルフォームズ、エルエルシー 活性剤との混合相共結晶の調製方法
DE102004062775A1 (de) 2004-12-21 2006-06-29 Stockhausen Gmbh Alkoholischer Pumpschaum
CN103417388A (zh) 2005-03-07 2013-12-04 戴博全球保健有限公司 含有有机硅表面活性剂的高醇含量发泡组合物
US8580860B2 (en) * 2007-02-23 2013-11-12 Gojo Industries, Inc. Foamable alcoholic composition
DE102007063133A1 (de) * 2007-12-24 2009-06-25 Sasol Germany Gmbh Verfahren zur Herstellung von Wachs in Wasser Dispersionen aus selbstemulgierenden Gelkonzentraten
DE102007063134A1 (de) * 2007-12-24 2009-06-25 Sasol Germany Gmbh Verfahren zur Herstellung von Öl in Wasser Emulsionen aus selbstemulgierenden Gelkonzentraten
EP2123606A1 (en) * 2008-05-19 2009-11-25 Kemira Pigments Oy Ultrafine titanium dioxide nanoparticles and dispersions thereof
AR080551A1 (es) * 2009-10-05 2012-04-18 Marrone Bio Innovations Derivados que contienen antraquinona como productos agricolas bioquimicos
US8637569B2 (en) 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
CN102711743A (zh) * 2009-10-22 2012-10-03 Api起源有限责任公司 含有黄酮类的组合物的制备和使用方法
WO2011133996A2 (en) 2010-04-30 2011-11-03 Kemira Oyj Aqueous dispersions for sizing paper
US20110275738A1 (en) * 2010-05-05 2011-11-10 Basf Se Process for producing finely divided suspensions by melt emulsification
EP2823811A1 (en) * 2013-07-09 2015-01-14 OTC GmbH Targeted active release system comprising solid lipid nano-particles
WO2021033482A1 (ja) * 2019-08-19 2021-02-25 Jsr株式会社 分散組成物、分散剤、異方性膜及びその製造方法、並びに異方性膜形成装置
AU2021226149A1 (en) * 2020-02-26 2022-10-06 Capcium Inc. Nanostructure lipid carrier delivery system, composition, and methods

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880634A (en) * 1984-06-08 1989-11-14 Dr. Rentschler Arzneimittel Gmbh & Co. Lipid nano-pellets as excipient system for perorally administered drugs
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU658608B2 (en) * 1991-03-25 1995-04-27 Astellas Pharma Europe B.V. Topical preparation containing a suspension of solid lipid particles
FR2681248B1 (fr) * 1991-09-13 1995-04-28 Oreal Composition pour un traitement cosmetique et/ou pharmaceutique de longue duree des couches superieures de l'epiderme par une application topique sur la peau.
DE4131562A1 (de) 1991-09-18 1993-03-25 Medac Klinische Spezialpraep Arzneistofftraeger aus festen lipidteilchen-feste lipidnanosphaeren (sln)
CA2091152C (en) * 1993-03-05 2005-05-03 Kirsten Westesen Solid lipid particles, particles of bioactive agents and methods for the manfuacture and use thereof
US5885486A (en) * 1993-03-05 1999-03-23 Pharmaciaand Upjohn Ab Solid lipid particles, particles of bioactive agents and methods for the manufacture and use thereof
US5747012A (en) * 1993-06-11 1998-05-05 Tioxide Specialties Limited Compositions containing sunscreens
DE4327063A1 (de) * 1993-08-12 1995-02-16 Kirsten Dr Westesen Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften
DE4341113B4 (de) * 1993-12-02 2006-04-13 IFAC Institut für angewandte Colloidtechnologie GmbH & Co. KG Stabile multiple X/O/Y-Emulsion
EP0766992B1 (en) * 1995-10-06 2003-07-30 ENITECNOLOGIE S.p.a. Nitrogen oxides reduction catalyst and process for reducing nitrogen oxides in exhaust gas
JP2001019609A (ja) * 1999-07-08 2001-01-23 Pola Chem Ind Inc 多相乳化剤形の皮膚外用剤
JP2002292270A (ja) * 2001-03-30 2002-10-08 Sunstar Inc 多相エマルジョン
JP4182195B2 (ja) * 2001-09-03 2008-11-19 独立行政法人農業・食品産業技術総合研究機構 単分散複合型エマルションの製造装置
EP1628626B2 (de) * 2003-05-07 2013-12-04 OTC GmbH Zusammensetzungen zur gezielten freisetzung von duftstoffen und aromen

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4880634A (en) * 1984-06-08 1989-11-14 Dr. Rentschler Arzneimittel Gmbh & Co. Lipid nano-pellets as excipient system for perorally administered drugs
US5188837A (en) * 1989-11-13 1993-02-23 Nova Pharmaceutical Corporation Lipsopheres for controlled delivery of substances

Also Published As

Publication number Publication date
WO2004082666A3 (de) 2005-05-12
JP2006520750A (ja) 2006-09-14
US20060257334A1 (en) 2006-11-16
DE10312763A1 (de) 2004-09-30
AU2004222631A1 (en) 2004-09-30
EP1605923A2 (de) 2005-12-21
CA2519697C (en) 2011-01-18
CA2519697A1 (en) 2004-09-30
WO2004082666A2 (de) 2004-09-30
KR20050114255A (ko) 2005-12-05

Similar Documents

Publication Publication Date Title
CA2519697C (en) Mssn dispersion and method for producing the same
CA2623112C (en) Method for producing ultrafine submicronic suspensions
US8663692B1 (en) Lipid particles on the basis of mixtures of liquid and solid lipids and method for producing same
Alsaad et al. Solid lipid nanoparticles (SLN) as a novel drug delivery system: A theoretical review
Lovelyn et al. Current state of nanoemulsions in drug delivery
US8716214B2 (en) Compositions for the targetted release of fragrances and aromas
AU747129B2 (en) Pharmaceutical compositions in form of nanoparticles comprising lipidic substances and amphiphilic substances and related preparation process
JP2002544155A (ja) 流体および固体脂質の混合物を基礎とする脂質粒子、およびそれらを製造するための方法
CZ289253B6 (cs) Způsob výroby nosiče pro léčiva zahrnujícího částice z lipidu, nosič léčiva a jeho pouľití
US7775704B2 (en) Device and method for continuously producing emulsions or dispersions
KR100654841B1 (ko) 피부유사구조 및 조성을 갖고 생리활성물질의 경피흡수를촉진하는 지질 용해부 조성물 및 이를 이용한 나노입자화장료의 제조방법
WO2014166994A1 (en) Nano-microdelivery systems for oral delivery of an active ingredient
US20160374951A1 (en) Targeted Active Release System Comprising Solid Lipid Nano-Particles
KR100553160B1 (ko) 코엔자임 큐10을 포함하는 나노크기의 인지질 리포좀조성물 및 그 제조방법
ZA200108794B (en) Lipid particles on the basis of mixtures of liquis and solid lipids and method for producing the same.
KR100778903B1 (ko) 과량의 친수성 생리활성물질을 함유한 나노 농축 캡슐조성물, 이의 제조방법 및 이를 함유한 화장료 조성물
KR100778946B1 (ko) 과량의 친유성 생리활성물질을 함유한 나노 농축 캡슐조성물, 이의 제조방법 및 이를 함유한 화장료 조성물
Khurana et al. 7 Multiple Emulsions
Benita et al. Cosmetic applications of colloidal delivery systems
KR20060004918A (ko) 에멀젼 또는 분산액을 연속적으로 제조하는 장치 및 방법
Demirbag et al. -Nanotechnology in Biomaterials: Nanoparticulates as Drug Delivery Systems

Legal Events

Date Code Title Description
PC1 Assignment before grant (sect. 113)

Owner name: KEMIRA PIGMENTS OY

Free format text: FORMER APPLICANT(S): IFAC GMBH & CO. KG

PC1 Assignment before grant (sect. 113)

Owner name: KEMIRA OYJ

Free format text: FORMER APPLICANT(S): KEMIRA PIGMENTS OY

FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired